CMO free? Novo Nordisk investing $760m in homegrown network
Novo Nordisk will invest up to $760m in its manufacturing network in the coming year to support the growth of its insulin portfolio.
Archives for February 3, 2015
US FDA calls industry to help address biosimilar interchangeability
The US FDA has reached out to industry for comments on the use of interchangeability data in the submission of biosimilars through the 351(k) pathway.